Category Archives: Business and Investments

Latest From Business and Investments

2015 FDA Approvals: Highest Levels in Over a Decade

btn-dave-thomas

2015 was a blockbuster year for FDA approvals of novel new medicines, many of them for serious and life-threatening conditions. As Dr. John Jenkins of the FDA’s Center for Drug Evaluation and Research (CDER) notes in a recent blog post, “During this past year, we approved many new drugs to treat various forms of cancer, including four to treat multiple myeloma, and others to treat lung, skin, breast, brain, colorectal, and other cancers. We also Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

Know Your IP Strategy: A Necessity for Technology Start-ups

Annemarie_Meike

The Licensing Executives Society Foundation invites start-up companies, with investments of less than $200,000, and graduate students from around the world to participate in their annual International Business Plan Competition. The Competition requires participants to submit a business plan with an intellectual property component and strategies explaining how intellectual property will be used to achieve business objectives. Before the first round submission deadline, the Competition pairs registered teams with senior leaders in the intellectual property Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post

Interstitial Cystitis: Understanding What It Is, and the Interstitial Cystitis Association’s Role in an IC Patient’s Life

scientist, lab

If you mention Interstitial Cystitis (IC) to most people, including physicians, the majority of people have no idea what you are talking about. This is alarming because IC affects between 4-12 million people, just in the U.S. alone.  The majority of IC patients are women, but both men and children can receive the diagnosis as well.  So what is IC and how do you know if you have it? Interstitial cystitis (in-ter-stish-uhl sĭ-stī’tĭs), or as Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post

The Liquid Gold Rush For Biopsies

Liquid biopsy is considered “liquid gold”. Estimates the global testing market to reach $20 billion by 2020.

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post

Setting the Record Straight on Innovation and Drug Development

stethoscope

Modern biotechnology is a relatively young industry, but in just over 40 years, the entrepreneurs, researchers and investors working in this field have firmly established themselves at the forefront of medical innovation and the search for new cures and therapies for previously untreatable diseases. That’s why it is important that policy proposals designed to respond to the activities of outliers like Turing Pharmaceuticals and Valeant do not hurt America’s leadership in biotechnology innovation and investment. Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,